Rituximab and intravenous immune globulin for desensitization during renal transplantation.
about
The Influence of Immunosuppressive Agents on the Risk of De Novo Donor-Specific HLA Antibody Production in Solid Organ Transplant RecipientsMonoclonal antibody therapy and renal transplantation: focus on adverse effectsBiologics in organ transplantationImmunologic considerations in heart transplantation for congenital heart diseaseBiologics in renal transplantationModern approaches to incompatible kidney transplantationTreatment options and strategies for antibody mediated rejection after renal transplantationIssues in solid-organ transplantation in children: translational research from bench to bedside.Rituximab in renal transplantationB cell repertoires in HLA-sensitized kidney transplant candidates undergoing desensitization therapyIncompatible live-donor kidney transplantation in the United States: results of a national surveyGuidelines on the Use of Therapeutic Apheresis in Clinical Practice-Evidence-Based Approach from the Writing Committee of the American Society for Apheresis: The Seventh Special Issue.Approach to the Highly Sensitized Kidney Transplant Candidate.Desensitization: Overcoming the Immunologic Barriers to TransplantationTherapeutic apheresis before and after kidney transplantation.The role of therapeutic apheresis in high immunologic risk renal transplantation: a review of current trends.Use of monoclonal antibodies in renal transplantation.Antibody desensitization therapy in highly sensitized lung transplant candidates.Acute hemolysis after high-dose intravenous immunoglobulin therapy in highly HLA sensitized patients.Autoimmunity as a predisposition for infectious diseasesPreemptive CD20+ B cell depletion attenuates cardiac allograft vasculopathy in cyclosporine-treated monkeys.Intravenous immunoglobulin therapy in kidney transplant recipients with de novo DSA: Results of an observational study.Patient-derived granulocyte/macrophage colony-stimulating factor autoantibodies reproduce pulmonary alveolar proteinosis in nonhuman primates.Preexisting donor-specific HLA antibodies predict outcome in kidney transplantationB-lymphocyte homeostasis and BLyS-directed immunotherapy in transplantation.Human T-follicular helper and T-follicular regulatory cell maintenance is independent of germinal centersRituximab for non-Hodgkin's lymphoma: a story of rapid success in translation.Diagnosis and management of antibody-mediated rejection: current status and novel approaches.IVIg treatment reduces catalytic antibody titers of renal transplanted patientsA closer look at rituximab induction on HLA antibody rebound following HLA-incompatible kidney transplantation.Infectious complications in kidney-transplant recipients desensitized with rituximab and intravenous immunoglobulin.Complete Removal of Extracellular IgG Antibodies in a Randomized Dose-Escalation Phase I Study with the Bacterial Enzyme IdeS--A Novel Therapeutic OpportunityUtility of HLA Antibody Testing in Kidney Transplantation.Heme Oxygenase-1 Inhibits HLA Class I Antibody-Dependent Endothelial Cell Activation.Outcome after Desensitization in HLA or ABO-Incompatible Kidney Transplant Recipients: A Single Center Experience.Living donor liver transplantation using sensitized lymphocytotoxic crossmatch positive graftImmune Profiles to Predict Response to Desensitization Therapy in Highly HLA-Sensitized Kidney Transplant CandidatesEffect of high-dose intravenous immunoglobulin on anti-HLA antibodies in sensitized kidney transplant candidatesTolerogenic therapies in transplantation.Assessment of variation in live donor kidney transplantation across transplant centers in the United States.
P2860
Q26774993-FF467169-2445-420F-86DB-3C3058F911C4Q26826880-6E326631-A211-4488-9450-530E5EF68D89Q26829578-AF7F2D79-8051-4DC5-9B32-D647E8A0B917Q26995790-45BDF98E-1AF3-4377-8EC7-81D6126627B0Q27009997-C6D52D30-19D7-48B7-B38F-58DB78DA39E0Q27010224-D81F169A-A43B-41D3-80C5-0EBE050910E5Q27021397-941AA705-B21A-4353-9975-A0759CCE60EBQ27023312-52B832B2-129D-46E2-B0BB-6B59170F69CBQ27026434-65A5F687-769B-4BE8-B941-6D45E8A6F74AQ28563989-1F48F996-1E70-419A-8494-34CCE314154EQ28741418-FCACDD11-D47A-4094-813E-904CB5A1A31CQ30276550-C64423B0-7035-4569-90A0-470164B9BCCBQ30277267-6658A7F9-C930-4C56-8FAE-52ED9A195468Q30397952-10183733-06A0-46CF-8611-4D98ACC9E98CQ30454250-102DD9EA-EE2A-4C5F-B712-76F435D5EC0BQ30455087-3E1C1C72-11EE-4642-982E-925CC40451BBQ33396236-3FA5CCC4-C587-42A9-9A08-2AD5F4057BB6Q33414196-A46D0390-5A26-4C9C-B4C6-9E6A6564D4EBQ33560520-50E7F0D2-A618-4BFB-BB6D-73631EFA923EQ33747588-E88FBA5D-39D3-4151-ADC3-295BD459C2EFQ33755443-2014A0A9-5216-4274-9BA2-9F7396E9E48AQ33842250-AE99512D-E050-4D2C-9403-94C9061C5EC6Q33988125-4E14EC37-66B9-422F-BC54-D1EBBB7CF8EDQ34124202-CC093259-C43F-4A72-999E-658DFCCED8B3Q34159016-2BE0772C-B14A-4153-A0A1-1C845017C0D6Q34398374-EB20F282-24A7-4143-BFBE-08A1C94678ACQ34687563-B06B62E9-5023-4F3E-B2C2-EAC176F1EF01Q34841849-52E304AF-37E8-47AA-AE15-F535DFA2FC4DQ34962680-8960268C-CFFD-4C89-AF5E-0B9D87675916Q35008036-123967EB-73F0-404C-A8D3-8850CDC26781Q35664634-932AB6D8-4C45-4836-A7B6-BC2E6115CABAQ35692718-760FA89A-F480-4500-844A-21FFFC195C12Q35790601-ACF83D50-3E5D-482E-82CE-A4622EF42465Q35874401-218D52BE-D18C-4C84-B54B-769B5D08023BQ35885244-2331048F-B08F-4EFD-8B85-B3065B7D8501Q35911619-12EBDFB4-EEF9-4E7A-9A26-4BEAA672AB29Q35990094-29265A0C-3121-4E90-A1AD-3D9807FA3B2BQ36053023-FA1137B6-FF72-41E2-90D9-42B3D78CA82BQ36102133-E36D9B3C-9250-4674-90DE-AE47EC3351A6Q36292000-4006FDDE-9C88-4888-BCDA-4339434D0C1C
P2860
Rituximab and intravenous immune globulin for desensitization during renal transplantation.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh-hant
name
Rituximab and intravenous immu ...... during renal transplantation.
@en
Rituximab and intravenous immu ...... during renal transplantation.
@nl
type
label
Rituximab and intravenous immu ...... during renal transplantation.
@en
Rituximab and intravenous immu ...... during renal transplantation.
@nl
prefLabel
Rituximab and intravenous immu ...... during renal transplantation.
@en
Rituximab and intravenous immu ...... during renal transplantation.
@nl
P2093
P356
P1476
Rituximab and intravenous immu ...... during renal transplantation.
@en
P2093
Alice Peng
Ashley A Vo
Chih-Hung Lai
Jennifer Wang
Marina Lukovsky
Mieko Toyoda
Nancy L Reinsmoen
Rafael Villicana
Stanley C Jordan
P304
P356
10.1056/NEJMOA0707894
P407
P577
2008-07-01T00:00:00Z